Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • knostrov
    Junior Member
    • Oct 2012
    • 7

    How much adapter contamination is common?

    Hi everybody,

    I am looking at my Fastq QC stats with much surprise: 25% of my reads contain Trueseq adapter sequences. That seems like a lot. I am completely new to NGS data analysis, so I have no point of comparison... is this very unusual? What type of analysis should I do to find out more about the roots of this problem?

    This is a 50bp PE run on a HiSeq 2000, target enrichment using Haloplex.

    Any comments would be appreciated.

    Thanks!
  • kopi-o
    Senior Member
    • Feb 2008
    • 319

    #2
    It sounds like a lot. Is it a special protocol, like small RNA sequencing? With very short insert sizes, you expect to see a lot of adapters in the reads. Maybe you could start by obtaining fragment size statistics from the lab.

    Comment

    • Wallysb01
      Senior Member
      • Feb 2011
      • 286

      #3
      That is a lot. In my experience it is <1%.

      Comment

      • jimmybee
        Senior Member
        • Sep 2010
        • 119

        #4
        Its very protocol specific. Some can have massive amounts of primer left after sequencing, so maybe fill us in on the sequencing experiment and what you did before sequencing?

        Comment

        • knostrov
          Junior Member
          • Oct 2012
          • 7

          #5
          Thank you for the quick replies. Actually I have by now realized that almost all of these contaminating sequences are reads that consist of nothing but adapter sequence, e.g. 50bp of read2-primersite--tag--adapter. I imagine those must be two linked adapters with no insert in between. One would think such constructs would be eliminated by size selection? Also their abundance varies per sample. They make up between 2-25% of all reads, depending on the sample.

          So the specifics of this sequencing experiment are (I did not do the experimental part myself...)
          - FFPE tissue samples, good DNA quality according to size distribution on gel
          - target enrichment using the Haloplex protocol (custom probes that hybridize to the two ends of a desired region to make a circle --> ligation --> circle amplification)
          - 50 bp PE run on HiSeq 2000

          Comment

          • MWN
            Junior Member
            • Aug 2011
            • 8

            #6
            Originally posted by knostrov View Post
            Thank you for the quick replies. Actually I have by now realized that almost all of these contaminating sequences are reads that consist of nothing but adapter sequence, e.g. 50bp of read2-primersite--tag--adapter. I imagine those must be two linked adapters with no insert in between. One would think such constructs would be eliminated by size selection? Also their abundance varies per sample. They make up between 2-25% of all reads, depending on the sample.

            So the specifics of this sequencing experiment are (I did not do the experimental part myself...)
            - FFPE tissue samples, good DNA quality according to size distribution on gel
            - target enrichment using the Haloplex protocol (custom probes that hybridize to the two ends of a desired region to make a circle --> ligation --> circle amplification)
            - 50 bp PE run on HiSeq 2000
            Any update?
            How much FFPE DNA do you use? Appreciate.

            Comment

            • swNGS
              Member
              • Nov 2011
              • 83

              #7
              For Haloplex, you really need to do adapter trimming before alignment, then clip 5 bases of the ends of each read, otherwise it suffers from biasing of the wild type allele if you get a variant at a restriction siteor probe binding site.
              Yes, you should be able to reduce them by size selection, but as a previous person said, have a look at the range of insert sizes (after establishing that trimming was done correctly, otherwise you'll lose a lot of potentially useful sequence). We are using Halo with 150 bp reads and I suspect we've got a bigger adapter read-through problem than you!

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 07-20-2026, 11:10 AM
              0 responses
              14 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-13-2026, 10:26 AM
              0 responses
              31 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-09-2026, 10:04 AM
              0 responses
              42 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-08-2026, 10:08 AM
              0 responses
              28 views
              0 reactions
              Last Post SEQadmin2  
              Working...